Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

2Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs’ by Sugahara and colleagues, published in Science in 2010 (<xref ref-type="bibr" rid="bib10">Sugahara et al., 2010</xref>). The key experiments being replicated include Figure 2 and Supplemental Figure 9A. In Figure 2, Sugahara and colleagues presented data on the tumor penetrance of doxorubicin (DOX) when co-administered with the peptide iRGD, as well as the effect of co-treatment of DOX and iRGD on tumor weight and cell death. In Supplemental Figure 9A, they tracked body weight of mice treated with DOX and iRGD to provide evidence that iRGD does not increase known DOX toxicity. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.

Cite

CITATION STYLE

APA

Kandela, I., Chou, J., Chow, K., Iorns, E., Gunn, W., Tan, F., … Errington, T. (2015). Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. ELife, 4(MAY), 1–14. https://doi.org/10.7554/eLife.06959

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free